Format

Send to

Choose Destination
N Engl J Med. 2011 Aug 4;365(5):385-8. doi: 10.1056/NEJMp1107285.

Developing the nation's biosimilars program.

Author information

1
U.S. Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD, USA.
PMID:
21812668
DOI:
10.1056/NEJMp1107285
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center